{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T11:54:30Z","timestamp":1792583670566,"version":"4.5.0"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Endocr Metab"],"published-print":{"date-parts":[[2013]]},"DOI":"10.4103\/2230-8210.113753","type":"journal-article","created":{"date-parts":[[2013,6,20]],"date-time":"2013-06-20T06:03:53Z","timestamp":1371708233000},"page":"628","source":"Crossref","is-referenced-by-count":26,"title":["Journey in guidelines for lipid management: From adult treatment panel (ATP)-I to ATP-III and what to expect in ATP-IV"],"prefix":"10.4103","volume":"17","author":[{"given":"Ashish","family":"Gulati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PG","family":"Talwalkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CG","family":"Sreenivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemang","family":"Baxi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/2230-8210.113753-1","first-page":"23","volume-title":"Lipids and risk of coronary heart disease.The Framingham Study","author":"Castelli","year":"1992","journal-title":"Ann Epidemiol"},{"key":"key-10.4103\/2230-8210.113753-2","unstructured":"National Cholesterol Education Program, Program description: The NCEP science base. Available from: http:\/\/www.nhlbi.nih.gov\/about\/ncep\/ncep_pd.htm. [Last Accessed on 2012 Mar 9]."},{"key":"key-10.4103\/2230-8210.113753-3","first-page":"1436","volume-title":"Statin trials and goals of cholesterol-lowering therapy","author":"Grundy","year":"1998","journal-title":"Circulation"},{"key":"key-10.4103\/2230-8210.113753-4","first-page":"11","volume-title":"Impact of the third cholesterol report from the adult treatment panel of the national cholesterol education program on the clinical laboratory","author":"Warnick","year":"2002","journal-title":"Clin Chem"},{"key":"key-10.4103\/2230-8210.113753-5","first-page":"36","volume-title":"The Expert Panel","author":"Report","year":"1988","journal-title":"Arch Intern Med"},{"key":"key-10.4103\/2230-8210.113753-6","first-page":"2486","volume-title":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)","author":"Expert","year":"2001","journal-title":"JAMA"},{"key":"key-10.4103\/2230-8210.113753-7","doi-asserted-by":"crossref","unstructured":"Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993;269:3015-23.","DOI":"10.1001\/jama.1993.03500230097036"},{"key":"key-10.4103\/2230-8210.113753-8","first-page":"2051","volume-title":"An evidence-based assessment of the NCEP Adult Treatment Panel II guidelines.National Cholesterol Education Program","author":"Ansell","year":"1999","journal-title":"JAMA"},{"key":"key-10.4103\/2230-8210.113753-9","first-page":"3143","volume-title":"Executive summary of the (NCEP) on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).Third Report of the National Cholesterol Education Program (NCEP) in Adults (Adult Treatment Panel III) final report","author":"National","year":"2002","journal-title":"Circulation"},{"key":"key-10.4103\/2230-8210.113753-10","first-page":"227","volume-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"key-10.4103\/2230-8210.113753-11","first-page":"53E","volume-title":"Recent National Cholesterol Education Program Adult Treatment Panel III update: Adjustments and options","author":"Stone","year":"2005","journal-title":"Am J Cardiol"},{"key":"key-10.4103\/2230-8210.113753-12","first-page":"89","volume-title":"Evolution of NCEP guidelines: ATP1-ATPIII risk estimation for coronary heart disease in 2002.National Cholesterol Education Program","author":"Conti","year":"2002","journal-title":"Clin Cardiol"},{"key":"key-10.4103\/2230-8210.113753-13","first-page":"2","volume-title":"Three reasons to abandon low-density lipoprotein targets: An open letter to the Adult Treatment Panel IV of the National Institutes of Health","author":"Hayward","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"key-10.4103\/2230-8210.113753-14","first-page":"979","volume-title":"Lipid disorders: Justification of methods and goals of treatment","author":"Braunstein","year":"2001","journal-title":"Chest"},{"key":"key-10.4103\/2230-8210.113753-15","first-page":"1407","volume-title":"Prevention of coronary heart disease in clinical practice.Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention","author":"Wood","year":"1998","journal-title":"J Hypertens"},{"key":"key-10.4103\/2230-8210.113753-16","first-page":"III8","volume-title":"HDL cholesterol and protective factors in atherosclerosis","author":"Assmann","year":"2004","journal-title":"Circulation"},{"key":"key-10.4103\/2230-8210.113753-17","first-page":"F17","volume-title":"Epidemiology of low HDL-cholesterol: results of studies and surveys","author":"Bruckert","year":"2006","journal-title":"Eur Heart J Suppl"},{"key":"key-10.4103\/2230-8210.113753-18","first-page":"515","volume-title":"American College of Physicians.Part 1","author":"Guidelines","year":"1996","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/2230-8210.113753-19","first-page":"882","volume-title":"A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction","author":"Stampfer","year":"1996","journal-title":"JAMA"},{"key":"key-10.4103\/2230-8210.113753-20","first-page":"S56","volume-title":"Management of dyslipidemia in adults with diabetes (position statement)","author":"American","year":"1999","journal-title":"Diabetes Care"},{"key":"key-10.4103\/2230-8210.113753-21","first-page":"S39","volume-title":"Effective management of patients with dyslipidemia","author":"Lipsy","year":"2003","journal-title":"Am J Manag Care"},{"key":"key-10.4103\/2230-8210.113753-22","first-page":"393","volume-title":"Report of the Adult Treatment Panel III: The 2001 National Cholesterol Education Program guidelines on the detection, evaluation and treatment of elevated cholesterol in adults","author":"Pasternak","year":"2003","journal-title":"Cardiol Clin"},{"key":"key-10.4103\/2230-8210.113753-23","unstructured":"National Cholesterol Education program. ATP III guidelines at-a-glance quick desk reference. Available from: http:\/\/www.nhlbi.nih.gov\/guidelines\/cholesterol\/atglance.pdf. [Last Accessed on 2012 Mar 15]."},{"key":"key-10.4103\/2230-8210.113753-24","first-page":"7","volume-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial","author":"Heart","year":"2002","journal-title":"Lancet"},{"key":"key-10.4103\/2230-8210.113753-25","first-page":"1623","volume-title":"Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomised controlled trial","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"key":"key-10.4103\/2230-8210.113753-26","first-page":"2998","volume-title":"The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)","author":"ALLHAT","year":"2002","journal-title":"JAMA"},{"key":"key-10.4103\/2230-8210.113753-27","first-page":"1149","volume-title":"Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial","author":"Sever","year":"2003","journal-title":"Lancet"},{"key":"key-10.4103\/2230-8210.113753-28","first-page":"1495","volume-title":"Pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 investigators.Intensive versus moderate lipid lowering with statins after acute coronary syndromes","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2230-8210.113753-29","unstructured":"National Heart Lung and Blood Institute. Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel IV). Available from: http:\/\/www.nhlbi.nih.gov\/guidelines\/cholesterol\/atp4\/index.htm. [Last Accessed on 2012 Mar 12]."},{"key":"key-10.4103\/2230-8210.113753-30","first-page":"520","volume-title":"Narrative review: Lack of evidence for recommended low-density lipoprotein treatment targets: A solvable problem","author":"Hayward","year":"2006","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/2230-8210.113753-31","first-page":"337","volume-title":"A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk","author":"Sniderman","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"key-10.4103\/2230-8210.113753-32","first-page":"356","volume-title":"An updated coronary risk profile.A statement for health professionals","author":"Anderson","year":"1991","journal-title":"Circulation"},{"key":"key-10.4103\/2230-8210.113753-33","first-page":"2243","volume-title":"C-reactive protein and parental history improve global cardiovascular risk prediction: The Reynolds Risk Score for men","author":"Ridker","year":"2008","journal-title":"Circulation"},{"key":"key-10.4103\/2230-8210.113753-34","first-page":"656","volume-title":"Monitoring cholesterol levels: measurement error or true change?","author":"Glasziou","year":"2008","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/2230-8210.113753-35","unstructured":"Available from: http:\/\/www.acli.com\/Events\/Documents\/Tue22812%20-%20Lipidology%20-%20Pamela%20Morris.pdf]. [Last Accessed on 2012 Jun 29]."},{"key":"key-10.4103\/2230-8210.113753-36","first-page":"581","volume-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: Meta-analysis of individual data from 27 randomised trials","author":"Cholesterol","year":"2012","journal-title":"Lancet"},{"key":"key-10.4103\/2230-8210.113753-37","first-page":"1781","volume-title":"The safety of statins in clinical practice","author":"Armitage","year":"2007","journal-title":"Lancet"},{"key":"key-10.4103\/2230-8210.113753-38","first-page":"1670","volume-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170,000 participants in 26 randomised trials","author":"Cholesterol","year":"2010","journal-title":"Lancet"},{"key":"key-10.4103\/2230-8210.113753-39","first-page":"735","volume-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials","author":"Sattar","year":"2010","journal-title":"Lancet"},{"key":"key-10.4103\/2230-8210.113753-40","first-page":"c3531","volume-title":"Shifting views on lipid lowering therapy","author":"Krumholz","year":"2010","journal-title":"BMJ"},{"key":"key-10.4103\/2230-8210.113753-41","first-page":"126","volume-title":"All-or-nothing treatment targets make bad performance measures","author":"Hayward","year":"2007","journal-title":"Am J Manag Care"},{"key":"key-10.4103\/2230-8210.113753-42","first-page":"69","volume-title":"Optimizing statin treatment for primary prevention of coronary artery disease","author":"Hayward","year":"2010","journal-title":"Ann Intern Med"}],"container-title":["Indian Journal of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:27:05Z","timestamp":1786649225000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/2230-8210.113753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"alternative-id":["113753"],"URL":"https:\/\/doi.org\/10.4103\/2230-8210.113753","relation":{},"ISSN":["2230-8210"],"issn-type":[{"value":"2230-8210","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]}}}